Ethical Aspects and Implications of Commercialization of Renal Transplantation: A Global Perspective

Read full text Summarise with VIRAT
Authors: Gerry George Mathew
Cited by: 0
References: 74

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

End-stage renal disease affects approximately 4.9 million individuals globally, with kidney transplantation providing optimal treatment outcomes. However, organ scarcity has led to commercial transplantation practices that raise significant ethical concerns. A comprehensive literature review using PubMed, EMBASE, and Cochrane databases (2010–2024), focusing on clinical outcomes, ethical frameworks, and regulatory policies regarding commercial transplantation, was conducted. Commercial transplantation accounts for 5%–10% of kidney transplants performed annually worldwide. Clinical outcomes demonstrate consistently inferior results compared to altruistic transplant systems, with higher perioperative complications (40%–65% vs. 10%–15%), increased acute rejection rates (30%–50% vs. 10%–20%), and reduced 5-year graft survival (60%–75% vs. 85%–90%). Ethical concerns include exploitation of vulnerable population, commodification of human organs, and violation of fundamental bioethical principles. Commercial renal transplantation presents complex ethical challenges requiring a comprehensive policy that address underlying organ shortage while protecting the vulnerable population and maintaining the highest clinical standards.

Fields of Study & Subjects

Organ Donation and Transplantation Ethics and bioethics in healthcare Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Indian Journal of Transplantation
Volume
20
Issue
1
Pages
9–16
Publication date
1 January 2026
Language
EN